1. Home
  2. BBW vs LXEO Comparison

BBW vs LXEO Comparison

Compare BBW & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Build-A-Bear Workshop Inc.

BBW

Build-A-Bear Workshop Inc.

HOLD

Current Price

$59.70

Market Cap

696.0M

ML Signal

HOLD

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

HOLD

Current Price

$10.56

Market Cap

663.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBW
LXEO
Founded
1997
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
696.0M
663.5M
IPO Year
2004
2023

Fundamental Metrics

Financial Performance
Metric
BBW
LXEO
Price
$59.70
$10.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
10
Target Price
$67.71
$18.90
AVG Volume (30 Days)
521.9K
1.5M
Earning Date
12-04-2025
11-05-2025
Dividend Yield
1.52%
N/A
EPS Growth
15.02
N/A
EPS
4.36
N/A
Revenue
$525,767,000.00
N/A
Revenue This Year
$8.05
N/A
Revenue Next Year
$4.31
N/A
P/E Ratio
$13.24
N/A
Revenue Growth
6.17
N/A
52 Week Low
$32.55
$1.45
52 Week High
$75.85
$10.99

Technical Indicators

Market Signals
Indicator
BBW
LXEO
Relative Strength Index (RSI) 66.91 62.18
Support Level $53.01 $10.32
Resistance Level $54.89 $10.99
Average True Range (ATR) 2.36 0.59
MACD 0.84 0.09
Stochastic Oscillator 97.57 77.95

Price Performance

Historical Comparison
BBW
LXEO

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

Share on Social Networks: